The global atropine sulfate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Atropine sulfate is used to treat a certain type of nerve agent and pesticide poisonings to reduce saliva, mucus, and other secretions during surgery. Therising market intervention by key market players is attracting the attention of investors across the globe. Atropine sulphate is used in the eye to increase the pupil size during the diagnosis of uveitis and early amblyopia. In addition, it is given intravenously or intramuscularly to treat bradycardia as the injection solution usually begins to work within a minute and lasts half an hour to one hour. Large doses may be needed to treat certain toxins. Atropine also acts as an antidote over toxins caused by organophosphate nerve toxins. The large application areas of this drug is further contributing to its market growth.
Looking towards the growing application areas of atropine sulphate, key market players such as Alchem International Pvt. Ltd., and Centroflora Group among others are adopting several growth strategies such new product launch and filing for FDA approval to remain competitive in the market place. For instance, in December 2021, Apotex Corp. has received approval and granted a Competitive Generic Therapy signation for its generic version of Atropine Sulfate Ophthalmic Solution USP, 1.0% by the US FDA. As the first approved application , Apotex has been granted 180 days of Competitive Generic Therapy exclusivity.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Atropine Sulfate Market at: https://orionmarketreports.com/request-sample/?id=92658&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Product Type
- By Application
- By Distribution Channel
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape-Alchem International Pvt. Ltd., Centroflora Group, Minsheng Group Shaoxing Pharmaceutical Co. Ltd., Novartis AG, and Resonance Laboratories Pvt. Ltd., among others.
A full report Atropine Sulfate Market of is available at: https://orionmarketreports.com/atropine-sulfate-market/92658/
Global Atropine Sulfate Market Report by Segment
By Product Type
- Injection
- Drops
- Gel
- Tablet
By Application
- Ophthalmology
- Gastrointestinal
- Neurology
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
